Vascarta Inc: Transdermal Curcumin (VAS-101 Drug Candidate) Interrupts the Neuroinflammatory Pathophysiological Cascade Associated with Acute Sickle Cell Crisis
PR Newswire —
SUMMIT, N.J., Nov. 3, 2025 /PRNewswire/ -- New findings demonstrating a reversal in acute vaso-occlusive pain in sickle cell disease by a novel transdermal curcumin gel formulation to be presented* at the 67th Annual American Society of Hematology meeting in Orlando. This study first...